No Paracetamol Needed For Children After COVAXIN Dose: Bharat Biotech
The Hyderabad-based Bharat Biotech advised not to give any pain killers, paracetamol or any other drug to children, who took COVID-19 vaccine doses. "No paracetamol or pain killers are recommended after being vaccinated by COVAXIN," said Bharat Biotech in a tweet. Reportedly, mild symptoms, which usually last for 1-2 days, can be resolved without any medication. However, the company also recommended consulting with a physician for medication… read-more
Tags: Covid-19, Paracetamol Tablet, children, Covaxin, Bharat biotech
Courtesy: The Print
DCGI Gives Nod To Bharat Biotech For Administering Covaxin To Kids
Hyderabad-based Bharat Biotech was granted emergency approval to administer the COVID-19 vaccine to kids between the age of 12 to 18 years by the Drug Controller General of India (DCGI), on December 25. Reportedly, the company has further started the regulatory process to make it available on CoWin platform. Biotech's vaccine has become the second vaccine to receive approval after Zydus Cadila's three-dose needle-free vaccine ZyCoV-D in India… read-more
Tags: Covaxin, Bharat biotech, DCGI, approval, kids
Courtesy: Money Control
Covaxin To Be Exported Internationally In December 2021
Hyderabad based manufacturer of Covaxin (Covid-19 vaccine) on November 29, announced to commence international export of the vaccine doses. The execution of the exportation was completed in November, and will now be shipped in December. The company thanked the Central Government (for export) and said, the vaccines will be exported to countries, which approved the emergency use of Covaxin. So far, only SII was allowed to export the Covid-19… read-more
Tags: Covaxin, Hyderabad, Global Export, Indian government, Vaccine Export
Courtesy: The Siasat Daily
Only Covaxin Gives 65.2% Efficacy Against COVID-19 Delta Variant: Lancet
The recent study by the Lancet peer-review said Covaxin surpassed all the vaccines in terms of efficacy against the Delta variant by providing 65.2% efficacy, said vaccine maker Bharat Biotech on November 12. The Lancet also said that it provides 77.8% efficiency against symptomatic patients. It provides ''70.8% protection against all variants of SARS-CoV-2 virus,'' said the maker. However, 12% of people experienced common side effects of the… read-more
Tags: Covid-19, Covaxin, Lancet, Bharat Bitotech, Study
Courtesy: Time Now News
Covaxin Maker Seeks Approval In US For Children Under 18 Years
Bharat Biotech's partner Ocugen on November 6, asked the US Food and Drug Administration (FDA) for the emergency use authorisation of Covaxin for children under 18 years. Earlier the vaccine was granted approval by the World Health Organisation (WHO) for its Emergency Use Listing (EUL). "We are pleased to announce our EUA filing to the US-FDA through our partners-Ocugen,"… read-more
Tags: covid 19, Coronavirus, Covaxin, Bharat biotech, FDA
Courtesy: ANI
WHO Gives Approval To Bharat Bitoech's Covaxin For Emergency Use
World Health Organisation's (WHO), Technical Advisory Group (TAG) reportedly gave Emergency Use Listing (EUL) status to Bharat Biotech's Covaxin on November 3. Covaxin has been found 77.8% effective against symptomatic COVID-19 and 65% against the new Delta Variant. The decision came after the WHO had sought more clarifications from the company on October 26. Covaxin has become the second Indian vaccine to get the status after Covishield. … read-more
Tags: WHO, emergency use, Bharat biotech, Covaxin, approval
Courtesy: The Times of India
Bharat Biotech's Covaxin Gets Guyana's Approval, Awaits WHO's Recognition
Guyana on November 2 announced that it has decided to add Bharat Biotech's Covaxin to its recognised list of COVID-19 vaccines. Notably, Australia also announced to recognise Covaxin as COVID-19 vaccine in its country on November 1. However, the company is still waiting for World Health Organisation's approval for Covaxin which will help it to get recognition from all the countries in the world.
Tags: Guyana, Covaxin, Bharat Bitotech, Covid-19, India
Courtesy: ANI
Australia Annonuces To Recongnise Covaxin As COVID-19 Vaccine
In a major boost to Bharat Biotech, Australia on November 1 announced that it's added the company's Covaxin to the list of approved COVID-19 vaccines in the country. The decision was announced by Australia's High Commissioner to India Barry O'Farrell on Twitter. Reportedly, the decision will help many who've received Covaxin and wants to travel to Australia. The country already recognises the Covishield Vaccine of AstraZeneca India.
Tags: Australia, Covaxin, Covid-19, vaccine, Bharat biotech
Courtesy: ANI
Oman Adds 'COVAXIN' To Its Approved List Of COVID-19 Vaccines
Oman On October 27 has decided to include "COVAXIN" on their country's approved list of Covid-19 vaccines. The Indian Embassy in Muscat said, "All passengers from India who have received two doses of Covaxin at least 14 days before estimated arrival date, will now be able to travel to Oman without the requirement of quarantine." However, COVID-19 protocols, such as the pre-arrival RT-PCR test will be mandatory.
Tags: Covid-19, Covaxin, Oman, Indian Embassy, Travel
Courtesy: ANI
WHO Requests Explanations On Covaxin; To Reconvene On November 3 For Final Review
WHO announced on October 26, that Technical-Advisory-Group (TAG) for Emergency-Use-Listing (EUL) has made the decision that added clarifications from Bharat-Biotech are required before a final EUL risk-benefit assessment for global use of Covaxin can be conducted. WHO stated that TAG “expects to receive these clarifications by the end of this week, and aims to reconvene on November 3”. Covaxin's acceptance by foreign countries is contingent… read-more
Tags: Covaxin, Bharat biotech, WHO, Emergency Use Authorization
Courtesy: The Indian Express